Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 376-382

  Tam, Robert C ^a   Pai, Bharati ^a   Bard, Josie ^a   Lim, Charmaine ^a   Averett, Devron R ^a   Phan, Uyen T ^a   Milovanovic, Tatjana ^a  

^a Valeant Pharmaceuticals International   (United States)

Author keywords

Antiviral immunity; Hepatitis C; T lymphocytes; Type 1 Type 2 cytokines

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; DRUG EFFECT; HEPATITIS C; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033024781     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80093-2     Document Type: Article

References (10)

1. Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med. 308:1983;1443-1447.
2. Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, et al. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol. 25:1996;591-598.
3. Mosmann TR, Sad S. The expanding universe of T cell subsets: Th1, Th2 and more. Immunology Today. 17:1996;138-146.
4. Powers CN, Peavy DL, Knight V. Selective inhibition of functional lymphocyte subpopulations by ribavirin. Antimicrob Agents Chemother. 22:1982;108-114.
5. Marquardt DL, Gruber HE, Walker LL. Ribavirin inhibits mast cell mediator release. J Pharmacol Exp Therap. 240:1987;145-149.
6. Hultgren C, Milich DR, Weiland O, Sällberg M. Ribavirin therapy shifts the T helper Th1/Th2 subset balance in vivo. [abstract] Gastroenterol Clin Biol. 21:1997;A92.
7. Ning Q, Brown D, Parodo J, Cattral M, Fung L, Gorczynski R, et al. Ribavirin inhibits viral-induced macrophage production of tumor necrosis factor, interleukin-l, procoagulant activity fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol. 160:1998;3487-3493.
8. Clarysse C, Nevens F, Pirenne J, Aerts R, Soumillion A, Roberts N, et al. Differential effect of IFN alpha-2B and ribavirin on the HCV-RNA level in primary cultures of human hepatocytes derived from chronic HCV carriers and of human hepatocytes in vitro. J Hepatol. 28:1998;95.
9. Reichard O, Norkans G, Fryden A, Braconicr J-H, Sonnerborg A, Weiland O. Randomized, double blind, placebo controlled trial of interferon alpha 2B with and without ribavirin for chronic hepatitis C. Lancet. 351:1998;83-87.
10. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naomov NV. Interferon induced virus specific T helper cell responses are associated with viral clearance in chronic HCV infection. [abstract] Hepatology. 26:1997;406A.